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Strengths and limitations of this study
 ► A whole country population- based study on Down 
syndrome, with comprehensive identification via all 
NHS Scottish Regional Genetics Centres.
 ► 25- Year period of linked data.
 ► Account taken of the potential confounders of age, 
sex and extent of neighbourhood deprivation; under-
lying conditions were not investigated.
 ► Some of the Down syndrome individuals could not 
be matched, mostly due to missing data on post-
code, and so were omitted from analyses.
 ► The use of routinely collected hospital and death 
statistics has many advantages including large- 
scale coverage, but there is likely to be a degree of 
coding inaccuracy which is not quantified.
AbStrACt
Objective To investigate current Down syndrome live birth 
and death rates, and childhood hospitalisations, compared 
with peers.
Setting General community.
Participants All live births with Down syndrome, 
1990–2015, identified via Scottish regional cytogenetic 
laboratories, each age–sex–neighbourhood deprivation 
matched with five non- Down syndrome controls. Record 
linkage to Scotland’s hospital admissions and death 
data.
Primary outcome HRs comparing risk of first 
hospitalisation (any and emergency), readmission for 
children with Down syndrome and matched controls were 
calculated using stratified Cox proportional hazards (PH) 
model, and length of hospital stay was calculated using a 
conditional log- linear regression model.
results 689/1479 (46.6%) female and 769/1479 (51.9%) 
male children/young people with Down syndrome were 
identified (1.0/1000 births, with no reduction over time); 
1235 were matched. 92/1235 (7.4%) died during the 
period, 18.5 times more than controls. More of the Down 
syndrome group had at least one admission (incidence 
rate ratio(IRR) 72.89 (68.72–77.32) vs 40.51 (39.15–
41.92); adjusted HR=1.84 (1.68, 2.01)) and readmissions 
(IRR 54.85 (51.46–58.46) vs 15.06 (14.36–15.80); 
adjusted HR=2.56 (2.08, 3.14)). More of their admissions 
were emergencies (IRR 56.78 (53.13–60.72) vs 28.88 
(27.73–30.07); first emergency admission adjusted 
HR=2.87 (2.61, 3.15)). Children with Down syndrome had 
28% longer first admission after birth. Admission rate 
increased from 1990–2003 to 2004–2014 for the Down 
syndrome group (from 90.7% to 92.2%) and decreased for 
controls (from 63.3% to 44.8%).
Conclusions We provide contemporaneous statistics 
on the live birth rate of babies with Down syndrome, and 
their childhood death rate. They require more hospital 
admissions, readmissions emergency admissions and 
longer lengths of stays than their peers, which has 
received scant research attention in the past. This 
demonstrates the importance of statutory planning as well 
as informal support to families to avoid added problems 
in child development and family bonding over and above 
that brought by the intellectual disabilities associated with 
Down syndrome.
IntrOduCtIOn
Improvements in health and social care and 
attitudes to disability have increased the 
survival of people with Down syndrome in 
recent decades.1–6 In England and Wales, it 
was estimated that there were 37 090 people 
with Down syndrome in 2011,7 but exact 
numbers are not reported. The National Down 
Syndrome Cytogenetic Register for England 
and Wales produces data on the estimated live 
birth rate for Down syndrome, using assump-
tions on termination rates for those receiving 
a prenatal diagnosis. In 2013, it reported an 
estimated live birth rate of 1.0/1000.8 In the 
USA, de Graaf et al9 estimated live birth and 
population prevalence for Down syndrome 
for all nine states in which data were avail-
able. They reported a live birth prevalence 
rate of 12.1/10 000, and an increase in the 
number of people living with Down syndrome 
from 1950 to 2010. In Canada, the live birth 
rate for Down syndrome was reported to have 
remained stable between 2005 and 2013, 
and higher than in the UK and USA rates, at 
approximately 13.5/10 000.10 Similar data are 
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not available for Scotland. Given the changing popula-
tion demographic for people with Down syndrome, and 
limited evidence base, we require a better understanding 
of their live birth rate and future health service needs.4
Down syndrome is associated with a range of congen-
ital anomalies, particularly cardiac, and a higher risk 
for respiratory, immunological, endocrine and gastro-
intestinal conditions.4 11 This phenotype puts people 
with Down syndrome at risk of hospitalisation. This may 
impact on their development and family relationships, 
and so is an added disadvantage on top of their intellec-
tual disabilities. Despite this, few previous studies have 
investigated hospitalisation of children and young people 
with Down syndrome, compared with the general popula-
tion. Fitzgerald et al12 studied hospital admissions of 405 
children with Down syndrome born in Western Australia 
between 1983 and 2004. They found that the children 
with Down syndrome were hospitalised five times more 
often when compared with previously published general 
population data for the single year of 1995. They had no 
general population comparison data for length of stay. 
Zhu et al13 investigated hospitalisations of 3212 children 
and adults with Down syndrome compared with 67 204 
children and adults without Down syndrome in Denmark, 
between 1977 and 2008. The people with Down syndrome 
had more than twice the rate of hospital admissions, 
and nearly three times as many bed days. Both studies 
found that length of admissions of the people with Down 
syndrome had reduced over the periods studied, and Zhu 
et al13 reported more bed days for males, children under 
5 years, and those with congenital heart anomalies. Other 
studies have lacked general population comparison data 
or been limited to single conditions. We are not aware of 
any large- scale studies specifically of children and young 
people with Down syndrome investigating these issues 
compared with their peers. There has been very little 
other investigation of the factors that influence length 
of hospital stay of children and young people with Down 
syndrome, and we located no studies on risk of readmis-
sion or on emergency admissions of children and young 
people.
Without accurate information on live birth and death 
rates, and hospital admission needs, it is not possible to 
plan for the healthcare support that children with Down 
syndrome and their families need.
This study’s aims were to investigate the (1) incidence 
of live births of people with Down syndrome over a 25- year 
period, (2) frequency of deaths of children and young 
people with Down syndrome compared with matched 
controls and (3) hospital admission frequency and dura-
tion, emergency admissions and readmissions of children 
and young people with Down syndrome compared with 
matched controls.
MethOdS
Written informed consent was not obtained from partici-
pants for their clinical records to be used in this study, but 
patient records were anonymised and de- identified prior 
to analysis. Safehaven approval was granted to approved 
researchers to analyse the data.
Patient and public involvement
This study was undertaken by the Scottish Learning 
Disabilities Observatory, which has a specific remit for 
people with intellectual disabilities, including people with 
Down syndrome; its steering group includes partners from 
third sector organisations, including Down Syndrome 
Scotland. Results from this study will be disseminated for 
people with Down syndrome and their families/carers 
in easy- read version via the Scottish Learning Disabilities 
Observatory website and newsletters.
Study sample, setting and process
All NHS Scottish Regional Genetics Centres (the east, 
north, south- east and west Scotland centres) identified all 
live birth infants screened positive for Down syndrome 
postnatally (live births with trisomy 21, mosaic trisomy 
21 or unbalanced translocation resulting in trisomy 21) 
between 1 January 1990 and 1 December 2015. In Scot-
land, everyone is given a unique Community Health Index 
(CHI) at birth which is used in their health records. The 
CHI database is held centrally by National Services Scot-
land (NSS), and was used to identify five controls without 
Down syndrome for each person with Down syndrome, 
matched on sex, age (by month and year of birth) and 
neighbourhood deprivation (using the Scottish Index 
of Multiple Deprivation (SIMD)).14 15 Down syndrome 
infants who could not be matched due to missing data or 
had less than 1 year of potential follow- up time (ie, births 
in 2015) were excluded from statisitcal analyses. The CHI 
also provides a means to record link each person iden-
tified with Down syndrome and their matched controls 
to routinely collected hospital admissions data (Scottish 
Morbidity Records 01: SMR01),16 and National Records 
of Scotland death certificate data.17 The end of the period 
of follow- up was 1 December 2015. However, children 
born in 2015 were excluded from the statistical analyses 
to allow a minimum potential follow- up time of 1 year for 
all children.
data sources and definitions
Live births
Live births of babies with Down syndrome from all NHS 
Scottish Regional Genetics Centres, 1990–2015; Scottish 
live births in the whole population, from the National 
Records of Scotland births time series, 1990–2015 (NRS, 
2019).17
Death
Deaths and causes of death by the International Classifi-
cation of Diseases codes18 according to death certificates 
registered at National Records of Scotland.
Hospital admissions
SMR01 contains episode- based records for all non- 
psychiatric, non- obstetric acute hospital admissions in 
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Scotland. The information collected includes the date 
of admission to hospital and discharge from it and 
whether the admission was routine or emergency. In 
SMR01, continuous periods of care are accounted for 
with a continuous inpatient stay (CIS) marker. This CIS 
marker ensures that a series of individual episodes over 
an unbroken period of care (eg, transfers between wards 
or hospitals) can be identified and treated as one admis-
sion rather than several admissions. Transfer of a baby 
to a neonatal intensive care unit after birth is counted as 
a first admission. Data quality assurance assessments for 
SMR01 are performed periodically.19 20
Admission type
Admission type is coded as emergency or routine. ‘Emer-
gency’ admissions are those which were unplanned in 
advance; planned admissions are ‘routine’ admissions.
Birth year group
Grouped into the most recent cohort (2004–2014) and 
the least recent cohort (1990–2003).
Scottish Index of Multiple Deprivation
SIMD matching with controls and reporting is by quin-
tiles, where SIMD 1 is the most deprived neighbourhoods 
and SIMD 5 is the most affluent neighbourhoods. SIMD 
is calculated at datazone level, identified from postcodes.
Discharge type
Discharge type is coded as a regular discharge or irreg-
ular discharge. Irregular discharges include, for example, 
a patient discharging himself/herself against medical 
advice, or death.
All follow-up/censoring
Children were followed up from birth, and all models 
were censored on death or 1 December 2015 (whichever 
came first) unless stated otherwise.
Analyses
Incidence of Down syndrome
Incidence of Down syndrome births was calculated for 
each calendar year from 1990 to 2015 inclusive.
Death
Incidence rates for mortality per person time (per 1000) 
were described, split by age group (for all ages, 0–1 month 
of life, from 1 to 12 months, from 13 to 60 months, from 
61 to 120 months, from 121 to 180 months and from 181 
to 240 months), as were underlying causes of death, for 
people with Down syndrome and their matched controls.
First hospital admissions
Incidence rates for first admissions per person time (per 
1000) for people with Down syndrome compared with 
controls were described, split by age group (for all ages, 
0–1 month, from 1 to 12 months and from 13+ months). 
Descriptive data for first admissions were presented 
including by sex, SIMD, year of birth and duration of 
first admissions in days, and this was compared using 
dependent t- tests for continuous variables and χ2 tests for 
categorical variables or Mann- Whitney U tests for length 
of hospital stay. The relative risk of first hospital admis-
sion was compared for people with Down syndrome and 
controls using stratified (by sex, birth year group, SIMD) 
Cox regression models (log–log plots confirmed the 
proportional hazards assumption was met). The follow- up 
period was defined as from date of birth until date of first 
admission, and admission type was entered as a potential 
confounder.
Risk of emergency hospital admission
The relative risk of emergency first hospital admission was 
compared for people with Down syndrome and controls, 
analysed using stratified (by sex, birth year group, SIMD) 
Cox regression models. The follow- up period was defined 
as from date of birth until date of first admission.
Duration of hospital admission
Conditional (stratified by sex, birth year group, SIMD) 
linear regression was used to model the duration of 
first hospital admission (log transformed to help negate 
potential skewing of results) as the outcome, comparing 
Down syndrome and control groups. Admission type was 
entered as a potential confounder.
Risk of readmission
The relative risk of readmission (the next admission after 
the first admission) was compared for people with Down 
syndrome and controls, analysed using stratified (by sex, 
birth year group, SIMD) Cox regression models. The 
follow- up period was defined as date of discharge from 
the first admission until date of the next admission. First 
admission type and discharge type from first admission 
were entered as potential confounders, and the interac-
tion of group (Down syndrome vs controls)*admission 
type (emergency vs routine) was included.
Reference groups for all regression analyses were: not 
having Down syndrome, females, most affluent neigh-
bourhoods, routine admissions and regular type of 
hospital discharges. All analyses were conducted with 
IBM SPSS V.22.
reSultS
Between 1 January 1990 and 1 December 2015, the Scot-
tish Regional Genetics Centres identified 1479 live births 
with Down syndrome. One thousand two hundred and 
thirty- five people were matched with 6175 controls. 
One hundred eighty- seven (12.6%) infants with Down 
syndrome were excluded from statistical analyses, as they 
could not be matched due to missing data on SIMD quin-
tile (n=160) in view of missing postcode information, 
sex (n=21), month and year of birth (n=<5) and CHI 
for example, due to migration out of Scotland (n=<5). 
A further 57 children were excluded as they were born 
in 2015 (and had less than 1 year of potential follow- up 
time). Of the 1479 infants born with Down syndrome, 689 
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Table 1 Incidence of Down syndrome by year of birth
Year of birth
Number of births 





1990 65 973 60 (0.09)
1991 67 024 66 (0.10)
1992 65 789 38 (0.06)
1993 63 337 35 (0.06)
1994 61 656 43 (0.07)
1995 60 051 46 (0.08)
1996 59 296 40 (0.07)
1997 59 440 72 (0.12)
1998 57 319 54 (0.09)
1999 55 147 52 (0.09)
2000 53 076 60 (0.11)
2001 52 527 61 (0.12)
2002 51 270 44 (0.09)
2003 52 432 58 (0.11)
2004 53 957 79 (0.15)
2005 54 386 63 (0.12)
2006 55 690 44 (0.08)
2007 57 781 70 (0.12)
2008 60 041 63 (0.10)
2009 59 046 73 (0.12)
2010 58 791 59 (0.10)
2011 58 590 63 (0.11)
2012 58 027 59 (0.10)
2013 56 014 58 (0.10)
2014 56 725 62 (0.11)
2015 55 098 57 (0.11)*
Total 1 508 483 1479 (0.10)
*In 2015, the Down syndrome total is for 11 months only, so the % 
in 2015 is adjusted to 11/12 months in the general population.
(46.6%) were girls, 769 (51.9%) were boys and sex was 
not recorded for 21 (1.4%). The proportion of births for 
the Down syndrome population by the five SIMD quin-
tiles were: 1=21.3%, 2=20.4%, 3=18.5%, 4=20.1% and 
5=19.7%, and SIMD data were missing for 160 (10.8%). 
Of the 1235 infants with Down syndrome with matched 
controls, 591 (47.9%) were girls and 644 (52.1%) were 
boys. The proportion of births for the Down syndrome 
population, by the five SIMD quintiles were: 1=21.0%, 
2=20.0%, 3=18.2%, 4=19.8% and 5=19.9%. Hence they 
appear to be representative of all the Down syndrome 
infants that were born.
Incidence of down syndrome live births over time
Given the total number of infants born was 1 508 483, 
the incidence of Down syndrome live births was 1479/1 
508 483 (1.0/1000 births). Table 1 and figure 1 show the 
incidence of Down syndrome live births for each year of 
the study period (with a moving average smoothed trend 
line to account for noise from year on year variation). 
The birth rate in Scotland has fallen since the early 1990s, 
while the incidence of Down syndrome shows some year- 
to- year variation and appears to have remained the same 
or risen since the early 1990s.
deaths
Of the 1235 people with Down syndrome with matched 
controls, 92 (7.4%) died during the study period (165 744 
person months of follow- up for the Down syndrome 
group), of whom 47 (51.0%) were women and 45 (48.9%) 
were men. Of the 6175 matched controls, 23 (0.4%) died 
during the period (895 776 person months follow- up 
for the controls), of whom 9 (39.1%) were women and 
14 (60.9%) were men. Death was therefore 18.5 times 
more common in the Down syndrome group. Most of 
the deaths of the people with Down syndrome occurred 
in infancy. Death incidence rates per person time (per 
1000) by age groups for the Down syndrome population 
versus controls were 0.56 (95% CI 0.45 to 0.68) (n=92) vs 
0.03 (95% CI 0.02 to 0.04) (n=23) for all ages, 17.81 (95% 
CI 9.87 to 32.17) (n=11) vs 0 for the first month of life, 
3.87 (95% CI 2.96 to 5.07) (n=53) vs 0.17 (95% CI 0.09 
to 0.29) (n=12) from 1 to 12 months, 0.36 (95% CI 2.96 
to 5.07) (n=18) vs 0.02 (95% CI 0.01 to 0.05) (n=6) from 
13 to 60 months, 0.15 (95% CI 0.07 to 0.32) (n=7) vs 0.01 
(95% CI 0.00 to 0.04) (n=<5) from 61 to 120 months, 0.09 
(95% CI 0.03 to 0.31) (n=<5) vs 0 from 121 to 180 months 
and 0 vs 0.02 (95% CI 0.00 to 0.08) (n=<5) from 181 to 240 
months. The most common certified underlying causes 
of death for the Down syndrome group were congenital 
heart anomalies (n=33, 34.4%), Down syndrome (n=26, 
27.1%) and infection (excludes respiratory infections) 
(n=11, 11.5%). This pattern was different compared with 
controls in whom causes of deaths were due to a range of 
other factors not found for people with Down syndrome 
(n=8, 34.8%), prematurity/perinatal causes (n=5, 21.7%) 
and congenital heart anomalies (n=5, 21.7%). Although 
less common than some other causes, leukaemia was a 
cause of death among people with Down syndrome 
(n=<5) compared with controls where no deaths were 
from leukaemia.
Admissions
Table 2 presents details on the first all- cause hospital admis-
sions for the two groups. One thousand one hundred and 
five people out of 1235 (89.5%) of the Down syndrome 
group had at least one hospital admission compared with 
3305/6175 (53.5%) of the control group. Admission inci-
dence rates per person time (per 1000) by age groups 
for the Down syndrome population versus controls were 
72.89 (95% CI 68.72 to 77.32) (n=1105) vs 40.51 (95% 
CI 39.15 to 41.92) (n=3305) for all ages, 38.87 (95% CI 
26.05 to 57.99) (n=24) vs 13.29 (95% CI 9.79 to 18.06) 
(n=41) for the first month of life, 56.44 (95% CI 52.03 to 
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Figure 1 Incidence of Down syndrome births by year in Scotland from 1990 to 2015.
Table 2 First all- cause hospital admissions characteristics
Down syndrome (n=1105) Control group (n=3305)
P valuen(%), Median (IQR) n(%), Median (IQR)
Age at admission (months) 0 (IQR=0–300) 24 (IQR=0–288) <0.001
Sex
  Male 572 (51.8%) 1840 (55.7%) <0.001
  Female 533 (48.2%) 1465 (44.3%)
Birth year group
  Most recent 577 (92.2%) 1468 (44.8%) <0.001
  Less recent 528 (90.7%) 1837 (63.3%)
SIMD
  Most affluent (5) 217 (19.6%) 570 (17.2%) <0.001
  4 226 (20.4%) 609 (18.4%)
  3 203 (18.4%) 591 (17.9%)
  2 230 (20.8%) 720 (21.8%)
  Most deprived (1) 229 (20.7%) 814 (24.6%)
Duration of admission (days) 2.00 (IQR=1.00–4.00) 1.00 (IQR=1.00–1.00) <0.001
Denominator for birth year group most recent/less recent are for Down syndrome n=653/582/control group n=3275/2900.
SIMD, Scottish Index of Multiple Deprivation.
61.23) (n=580) vs 24.94 (95% CI 23.62 to 26.33) (n=1298) 
from 1 to 12 months, 117.47 (95% CI 107.62 to 128.22) 
(n=501) vs 74.55 (95% CI 71.32 to 77.92) (n=1966) from 
13+ months. Compared with the control group, the Down 
syndrome group were younger at the time of first hospital 
admission (median=0 months (IQR 0–300 months) vs 
24 months (IQR 0–288)), had less admissions among 
females, were more equally spread across neighbour-
hoods while the control group had a gradient across SIMD 
groups with those in the most deprived areas having more 
hospital admissions, and had longer duration of admis-
sions (5.03 days (median=2.00; IQR=1.00–4.00), vs 1.78 
days (median=1; IQR=1.00–1.00)) by 3.25 days. The rate 
of admissions slightly increased over time for people with 
Down syndrome (from 528, 90.7% (in 1990–2003) to 577, 
92.2% (in 2004–2014)) and decreased for controls (from 
1837, 63.3% (in 1990–2003) to 1468, 44.8% (in 2004–
2014)). The gap between the higher rate of admissions 
has widened over time for people with Down syndrome 
compared with controls.
Emergency admission incidence rates per person time 
(per 1000) by age groups for the Down syndrome popu-
lation versus controls were 56.78 (95% CI 53.13 to 60.72) 
(n=861) vs 28.88 (95% CI 27.73 to 30.07) (n=2352) for all 
ages, 27.53 (95% CI 17.12 to 44.23) (n=17) vs 11.03 (95% 
CI 7.88 to 15.43) (n=34) for the first month of life, 48.66 
(95% CI 44.57 to 53.11) (n=500) vs 20.42 (95% CI 19.23 
to 21.69) (n=1063) from 1 to 12 months, 80.66 (95% CI 
72.57 to 89.65) (n=344) vs 47.71 (95% CI 45.14 to 50.42) 
(n=1255) from 13+ months. Table 3 displays the results 
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Table 3 Risk for first all cause hospital admission
Separately entered Simultaneously entered
HR value 95% CI HR value 95% CI
Group
  No Down syndrome ref ref ref ref
  Down syndrome 2.74† 2.52 to 2.98 1.84† 1.68 to 2.01
First admission type
  Routine ref ref ref ref
  Emergency 1.10* 1.00 to 1.20 1.19† 1.08 to 1.30
Stratified models by sex, birth year group, SIMD.
*P<0.05.
†P<0.001.
SIMD, Scottish Index of Multiple Deprivation.
Table 4 Risk for first emergency hospital admission
Separately entered
HR value 95% CI
Group
  No Down syndrome ref ref
  Down syndrome 2.87* 2.61 to 3.15
Stratified models by sex, birth year group, SIMD.
*P<0.001.
of the Cox regressions for time to first all- cause hospital 
admission. The risk of admission was higher among 
people with Down syndrome compared with controls, 
with an unadjusted HR=2.74 (95% CI 2.52 to 2.98). 
This remained after adjusting for type of first admission: 
HR=1.84 (95% CI 1.68 to 2.01).
Table 4 displays the results of the Cox regressions for 
time to first emergency hospital admission. The risk of 
emergency admission was higher among people with 
Down syndrome compared with controls, with a HR=2.87 
(95% CI 2.61 to 3.15).
duration of hospitalisation
The duration of first hospital admission was signifi-
cantly longer for the Down syndrome group at 5.03 days 
(median=2 days) versus 1.78 days (median=1 day) by 
3.25 days. After adjustment (with a log transformed 
time variable, to help account for any data skew) for 
sex, birth year group, SIMD and type of admission, the 
Coefficient=0.25 (95% CI 0.22 to 0.28) (table 5). This 
log transformed coefficient can be interpreted as a 
ratio of difference for the Down syndrome population 
compared with the control group (exponentiate of the 
log transformed coefficient, exp(0.248)=1.28145993219–
1×100=28, with a baseline length of stay (intercept) 
exp(0.12)=1.12749685158). This means the average 
length of stay was 28% higher in the Down syndrome 
population, compared with the controls. All exponenti-
ated values are presented as percentages in table 5.
risk of readmission
Of the Down syndrome group, 945/1105 (85.5%) had 
at least one readmission, compared with 1685/3305 
(51.0%) of the control group. Readmission incidence 
rates per person time (per 1000) for the Down syndrome 
population versus controls were 54.85 (95% CI 51.46 
to 58.46) (n=945) vs 15.06 (95% CI 14.36 to 15.80) 
(n=1695). The baseline age at readmission was lower for 
the Down syndrome group with a median age of 6 months 
(IQR 1–17) compared with the controls with a median 
age of 11 months (IQR 5–20; p<0.001). The unadjusted 
HR of Down syndrome for time to readmission following 
discharge from first admission was 2.44 (95% CI 2.13 
to 2.79). The HR when adjusted for type of admission, 
type of first discharge and group*emergency interaction 
was 2.56 (95% CI 2.08 to 3.14). Results are displayed in 
table 6.
dISCuSSIOn
Principal findings and interpretation
We found the Scottish incidence of Down syndrome live 
births to be 1.0/1000 births over the last 25 years, with it 
being possibly higher now than in the early 1990s. The 
Scottish birth rate has fallen overall, but incidence of 
Down syndrome has not. Death rate was 18.5 times higher 
for the children/young people with Down syndrome than 
for their controls, and their causes of death differed, 
including causes that might be expected to have been 
amenable to good healthcare such as infections.
Over a 25- year period, we found that children/young 
people with Down syndrome compared with matched 
controls were considerably more likely to have had at 
least one hospital admission (IRR of 72.89 compared with 
40.51; adjusted HR=1.84) and readmissions (IRR of 54.85 
compared with 15.06; adjusted HR=2.56). Their admis-
sions were more likely to have been emergency admis-
sions (IRR of 56.78 compared with 28.88; first emergency 
admission HR=2.87) and of longer duration 28% longer 
first admission after birth. Given the higher rate of first 
emergency admissions in the Down syndrome group, we 
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Table 5 Duration of first all- cause hospital admission (log transformed time variable)
Separately entered Simultaneously entered
Coef 95% CI Exp % Coef 95% CI Exp %
Group
  No Down syndrome ref ref 27 ref ref 28
  Down syndrome 0.24* 0.21 to 0.27 0.25* 0.22 to 0.28
First admission type
  Routine ref ref 2 ref ref 4
  Emergency 0.02 0.00 to 0.04 0.04* 0.02 to 0.06
Stratified models by sex, birth year group, SIMD.
*P<0.001.
Exp %, exponentiated values as percentages; Coef, Coefficient.
Table 6 Risk of readmission following discharge from first admission
Separately entered Simultaneously entered
HR value 95% CI HR value 95% CI
Group
  No Down syndrome ref ref ref ref
  Down syndrome 2.44† 2.13 to 2.79 2.56† 2.08 to 3.14
First admission type
  Routine ref ref ref ref
  Emergency 0.97* 0.83 to 1.13 1.39 1.05 to 1.84
Discharge type
  Routine ref ref ref ref
  Irregular 0.86 0.83 to 0.89 0.85 0.82 to 0.88
Group* first admission type
  – – – 1.06 0.78 to 1.44
Stratified models by sex, birth year group, SIMD.
*P<.05.
†P<0.001.
included the interaction of group×type of first admission 
(emergency or routine) in the analysis of readmissions, 
but they still remained more likely to be readmitted. We 
are not aware of any previous study of readmissions and 
emergency admissions in this population. The rate of 
admissions slightly increased over time (from 1990–2003 
to 2004–2014) for the children/young people with Down 
syndrome (from 90.7% to 92.2%), while it decreased 
for the control group (from 63.3% to 44.8%), perhaps 
reflecting changes in medical practice over time, to keep 
children out of hospital as far as possible, but admitting 
for serious problems which the Down syndrome chil-
dren may be more likely to experience. These findings 
are important, as they demonstrate the impact of addi-
tional health needs to both children and young people 
with Down syndrome, and to their families. This demon-
strates the importance of statutory as well as informal 
support to families to avoid added problems in child 
development over and above the intellectual disabilities 
that the children with Down syndrome experience, and 
the impact caring can have on families. Additionally, the 
high rates of emergency admissions and readmissions 
may indicate some poorer quality management of health-
care at the primary care level (to avoid admissions), and 
have not to our knowledge been reported before, though 
other factors, including underlying health conditions 
may contribute.
The Down syndrome group were younger at the time 
of first hospital admission, had a more equal sex distri-
bution for first admission than the control group and 
an equal distribution across extent of neighbourhood 
deprivation, while the control group had a gradient with 
those in the most deprived areas more likely to have had a 
hospital admission. This suggests that at present, the chil-
dren with Down syndrome appear to receive comparable 
care in terms of first admission, regardless of their neigh-
bourhood, and highlights that findings in the general 
population cannot be relied on when planning services 
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for people with Down syndrome/intellectual disabilities, 
such as focussing services in areas of greatest depriva-
tion. Families of children and young people with Down 
syndrome need focused support regardless of the areas 
they reside in.
Comparison with previous literature
As well as being 18.5 times more likely to die than their 
controls, we found that the children/young people 
with Down syndrome were more likely to be hospital-
ised, emergency hospitalised, readmitted and for longer 
durations. We have not identified any previous studies 
on readmission with which to compare our findings, 
nor on emergency admissions. For the earlier period of 
1977–2008 in Denmark, Zhu et al13 reported that children 
and adults with Down syndrome had more than twice 
the rate of hospital admissions (all admissions, not sepa-
rately reported for first admissions or repeat admissions), 
similar to our adjusted HRs for first and repeat admis-
sions, but we specifically investigated children and young 
people unlike that study. The smaller Australian study for 
the earlier period of 1983–2004 suggested that the hospi-
talisation rate was five times higher, but relied on previ-
ously reported general population data from 1995.12
As our study shows, and as previously reported in a 
study of children with Down syndrome identified from 
population- based sources in 1997 (n=210) and 2004 
(n=208) in Western Australia,21 it is highly likely that 
admission rates change over time, so these two studies are 
not strictly comparable to ours, and we have found no 
studies contemporaneous with ours with which to draw 
comparisons. Previously, small- scale studies reported 
length of admissions of children with Down syndrome to 
be 4.7 days in a Swedish study of 211 children followed up 
for at least 17 years,22 and 7 days specifically for bronchi-
olitis in a small retrospective case–control study in Singa-
pore,23 compared with the 5.0 days we found. A further 
small study of 213 children with Down syndrome aged 
0–3 years in America reported high admission rates.24
The live birth incidence for Down syndrome we report 
is similar to that recently reported in England, USA and 
Canada.8–10 Antenatal screening changes may underlie 
the variability in the birth rates found over time. Previous 
research in Scotland showed that decisions to terminate 
pregnancy following antenatal diagnosis of aneuploidy 
had fallen over time,1 which our results are also possibly 
suggestive of from the early 1990s to more recently. In 
contrast, in some other countries (eg, Denmark), following 
the introduction of antenatal combined screening for 
Down syndrome in 2004, there was a concurrent increase 
in prenatal diagnoses and the number of Down syndrome 
live births decreased suddenly and significantly before 
then stabilising.25 A higher proportion of the Scottish 
population have catholic faith compared with Denmark 
which might contribute in part to differences between 
countries: a range of complex factors influence women’s 
decision making regarding prenatal screening and diag-
nosis of Down syndrome, and it is possible that more 
societal acceptance of diversity and people with disabili-
ties, or better availability of family support may influence 
decisions in Scotland over time,1 26 although this requires 
further investigation.
Strengths and limitations
This is the first population- based study examining inci-
dence of Down syndrome and healthcare utilisation over 
time in Scotland compared with the general population, 
and the first worldwide to investigate emergency hospital 
admissions and readmissions. It controlled for the poten-
tial confounders of age, sex and SIMD. It was not subject 
to selection bias, as the population identification was 
based on routine data sources from all genetic service 
laboratories in Scotland (ie, the whole population). The 
Cox regression analysis for risk of admissions and read-
missions provides advantages over logistic or linear tech-
niques as this includes consideration of time to event 
(person time at risk). However, there were some missing 
control data, mostly due to missing postcodes, and this is 
a limitation of the study. There were no data on ethnicity 
which is a limitation; the Scottish population is 96% white. 
The use of routinely collected hospital and death statistics 
has many advantages including large- scale coverage, but 
there is likely to be a degree of coding inaccuracy which 
is not quantified. Children with Down syndrome have 
higher risk of comorbidities, so may be more likely to be 
transferred to neonatal intensive care units which might 
explain the increased risk of first hospital admission 
rates, but we could not distinguish such admissions in our 
dataset. We did not aim to investigate underlying condi-
tions which are associated with admissions and death in 
the two groups.
COnCluSIOnS
As people with Down syndrome are living longer than 
in the past, we have provided contemporaneous statis-
tics for the live birth rate of babies with Down syndrome 
and their childhood death rate compared with peers. We 
have found that their increasing survival is not without 
health consequences for the child, their family and 
health services—we report the majority require hospital 
admissions, readmissions and longer lengths of stays 
than their peers, which has received scant research atten-
tion in the past. Some factors may even suggest poorer 
healthcare than their peers, such as higher rates of emer-
gency admissions, although we did not aim to investigate 
the conditions associated with admission. Together this 
brings important new findings necessary to address the 
challenge of planning support that children with Down 
syndrome and their families need. They require adequate 
healthcare, and also an awareness of the impact that 
hospitalisation can have on child development and family 
bonding. There may be a need to develop tailored pack-
ages of support for families with children/young people 
with Down syndrome to cope with the higher healthcare 
needs of their offspring.
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